Product Images Medroxyprogesterone Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Medroxyprogesterone Acetate NDC 66993-371 by Prasco Laboratories, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - medroxyprogesterone 01

Figure 1 - medroxyprogesterone 01

This text is displaying odds ratio and confidence intervals for different studies related to DMPA usage. The displayed odds ratio is on a logarithmic scale. The text shows odds ratios for different time periods of DMPA usage and indicates increased risk for DMPA usage through a ratio greater than 1.*

Chemical Structure - medroxyprogesterone 02

Chemical Structure - medroxyprogesterone 02

Logo - medroxyprogesterone 03

Logo - medroxyprogesterone 03

Image - medroxyprogesterone 04

Image - medroxyprogesterone 04

This text appears to be a list of different birth control methods available. The first part of the text is likely showing the rates of pregnancy using different methods. The methods listed include injections, intrauterine devices, sterilization, birth control pills, patches, vaginal rings, condoms, diaphragms, spermicides, and withdrawal. The final line states "No birth control."*

Logo - medroxyprogesterone 05

Logo - medroxyprogesterone 05

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Label - medroxyprogesterone 06

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Label - medroxyprogesterone 06

This is a description for MedroxyPROGESTERone Acetate Injectable Suspension, USP with a concentration of 150 mg/mL. It is meant for intramuscular use only and comes in a single-dose vial. The medication should be shaken vigorously before each use and stored upright. The NDC number for this medication is 66993-370-83 and it is distributed by Prasco Laboratories in Mason, OH. For further information, refer to the package insert.*

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - medroxyprogesterone 07

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - medroxyprogesterone 07

This is a description of a medication called Medroxyprogesterone Acetate Injectable Suspension in a 1mL single-dose vial intended for intramuscular use only. It contains 150mg of medroxyprogesterone acetate and other ingredients such as polyethylene glycol, polysorbate 80, and sodium chloride. The medication may only be prescribed by a physician and comes with accompanying prescribing information. The vials must be stored upright at controlled room temperature. The medication is distributed by Prasco Laboratories in the USA.*

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - 66993-370-25 - medroxyprogesterone 08

PRINCIPAL DISPLAY PANEL - 150 mg/mL Vial Carton - 66993-370-25 - medroxyprogesterone 08

This appears to be a description of a medication containing medroxyprogesterone acetate in an injectable suspension form, with instructions for dosage and use. It includes some details on the ingredients and how to properly prepare and administer the medication.*

PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Label - medroxyprogesterone 09

PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Label - medroxyprogesterone 09

This is a single-use syringe containing Medroxyprogesterone Acetate Injectable Suspension, a medication used for intramuscular use only. The syringe is 1 mL and contains 150 mg per mL. The medication is prescription-only and should be shaken vigorously before use. It is distributed by Prasco Laboratories in Mason, OH. The LOT/EXP number is not available.*

PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Carton - medroxyprogesterone 10

PRINCIPAL DISPLAY PANEL - 150 mg/mL Syringe Carton - medroxyprogesterone 10

This text provides information about the dosage and use of the Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg/mL. The medication should be stored at a controlled room temperature between 20° and 25°C. The medication contains medroxyprogesterone acetate and other ingredients such as polystyrene glycol, polysorbate, and sodium chloride. The pH of the suspension may be adjusted with sodium hydroxide and/ or hydrochloric acid. The medication is for intramuscular use only and the syringe should be prepared by shaking it before use, removing the protective cap, attaching the needle to the syringe barrel, removing the safety shield from the needle, and administering the dose. trademarked products mentioned are Terumo® and SurGuard®.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.